End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.35 CNY | -18.75% |
|
-.--% | -45.40% |
06-25 | Hainan Poly Pharm Gets Nod to Market Voriconazole Injection in Denmark | MT |
06-24 | Hainan Poly Pharm Gets US FDA Marketing Nod for Antibacterial Injection | MT |
Business Summary
Number of employees: 1,522
Sales per Business
CNY in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Antibiotics
24.1
%
| 447 | 29.6 % | 435 | 24.1 % | -2.72% |
Cardiovascular Drugs
18.3
%
| 266 | 17.6 % | 331 | 18.3 % | +24.34% |
Antiallergic Drugs
14.5
%
| 294 | 19.5 % | 262 | 14.5 % | -10.80% |
Gastrointestinal Drugs
13.1
%
| 155 | 10.3 % | 236 | 13.1 % | +52.06% |
Others
10.0
%
| 150 | 9.9 % | 180 | 10.0 % | +20.48% |
First Aid Medicine
9.1
%
| - | - | 164 | 9.1 % | - |
Non-steroidal Anti-inflammatory Drugs
7.1
%
| 119 | 7.9 % | 129 | 7.1 % | +8.55% |
Dermatological Drugs
3.9
%
| 79 | 5.2 % | 70 | 3.9 % | -11.51% |
Sales per region
CNY in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
China
83.7
%
| 1,277 | 84.7 % | 1,511 | 83.7 % | +18.30% |
International
16.3
%
| 231 | 15.3 % | 295 | 16.3 % | +27.57% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Min Hua Fan
CEO | Chief Executive Officer | 63 | 13/07/92 |
Tong Ning Luo
DFI | Director of Finance/CFO | 49 | 30/09/04 |
Ji Ping Wang
BRD | Director/Board Member | 52 | 30/06/10 |
Mao Zhou
BRD | Director/Board Member | 54 | 30/09/12 |
Hui Fang Xie
BRD | Director/Board Member | 43 | 30/09/04 |
Shi Jun Wu
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Shu Ge Jiao
BRD | Director/Board Member | 58 | 31/05/15 |
Min Hua Fan
CEO | Chief Executive Officer | 63 | 13/07/92 |
Hui Fang Xie
BRD | Director/Board Member | 43 | 30/09/04 |
Mao Zhou
BRD | Director/Board Member | 54 | 30/09/12 |
Tong Ning Luo
DFI | Director of Finance/CFO | 49 | 30/09/04 |
Ji Ping Wang
BRD | Director/Board Member | 52 | 30/06/10 |
Ya Dong Chen
BRD | Director/Board Member | 54 | 25/11/18 |
De Zhu Fan
BRD | Director/Board Member | 58 | 25/11/18 |
Yu Ding
CHM | Chairman | 43 | 30/11/08 |
Lei Pan
BRD | Director/Board Member | 40 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 455,008,088 | 261,896,449 ( 57.56 %) | 3,232,923 ( 0.7105 %) | 57.56 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
4,191,623 | 1.30% | 7,148,603 $ |
Company contact information
Hainan Poly Pharm. Co., Ltd.
Guilinyang Economic Dev Zone Meilan District
571127, Haikou
+
http://www.hnpoly.com![address Hainan Poly Pharm. Co., Ltd(300630)](https://cdn.zonebourse.com/static/address/36818706.png)
Sector
Sales per Business
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-45.40% | 763M | |
+55.19% | 815B | |
+45.37% | 654B | |
-6.09% | 354B | |
+21.92% | 337B | |
+19.66% | 247B | |
+3.56% | 229B | |
+14.00% | 219B | |
+10.86% | 171B | |
-2.78% | 159B |
- Stock Market
- Equities
- 300630 Stock
- Company Hainan Poly Pharm. Co., Ltd